Since first introduced in the year 2000 King Guide y-site compatibility wall charts have been a proven, useful reference to have visible in the hospital and pharmacy for situations where a quick 'yes' or 'no' answer is needed. With 122 IV drugs and 4 infusion fluids the wall charts provide a comprehensive view of compatibility for Critical Care Admixtures and Chemotherapy Admixtures on a laminated 27" x 27" wall chart. The information on the charts is updated each year with data from the complete King® Guide to Parenteral Admixtures® database of over 600 fully referenced, peer-reviewed injectable drug compatibility and stability monographs.
Wall charts provide a convenient centralized offline way to quickly confirm the advisability of mixing intravenous drugs and a simple way to determine if more in-depth information is needed from the full text monographs provided in the complete King® Guide to Parenteral Admixtures®.
Wall charts provide IV compatibility information at the point of care. Having easy access to this information saves valuable time by reducing the need to call the pharmacy and provides nurses valuable information to confirm and verify drug compatibility questions prior to patient administration.
Wall charts provide a convenient way to quickly confirm the advisability of mixing intravenous drugs.
Designed to report y-site compatibility of intravenous drugs commonly administered to patients in the hospital, in emergency, and in home care/hospice. Includes new studies that appeared in the complete King Guide throughout 2023.
Includes: 4 Infusion Fluids and 122 injectable drugs (View Drugs)
For 2024 we updated y-site compatibility for:
Also available in French:
Compatibilité de médicaments administrés par voie IV à l'aide d'un dispositif en Y
Conçu pour signaler la compatibilité y-site des médicaments intraveineux couramment administrés aux patients à l’hôpital, en cas d’urgence et en soins à domicile / hospice. Comprend de nouvelles études qui sont apparues dans le King Guide complet tout au long de 2023.
Designed to report y-site compatibility of intravenous drugs commonly administered to patients receiving chemotherapy. The 2024 edition has been updated with new studies that appeared in the complete King Guide to Parenteral Admixtures throughout 2023.
4 Infusion Fluids
122 intravenous drugs including antibiotics and TPN solutions (View Drugs)